Principal Statistical Programmer FSP
- Discuss this with your agent
- Open in Claude
- Open in ChatGPT
Prepare application
- Draft this with your agent
- Open in Claude
- Open in ChatGPT
Role details
Tech stack
Job description
Sponsor-dedicated: Working fully embedded within one of our pharmaceutical clients, with the support of Cytel right behind you, youâll be at the heart of our clientâs innovation. As a Senior Statistical Programmer you will be dedicated to one of our global pharmaceutical clients; a company that is driving the next generation of patient treatment, where individuals are empowered to work with autonomy and ownership. This is an exciting time to be a part of this new program. Position Overview: As a Senior Statistical Programmer, you will leverage your advanced SAS programming skills and proficiency in CDISC standards (SDTM & ADaM) to support or lead one or more Phase I-IV clinical trials. This role can be performed as fully remote. Our valuesWe believe in applying scientific rigor to reveal the full promise inherent in data.We nurture intellectual curiosity and encourage everyone to approach new challenges with enthusiasm and the desire for discovery.We believe in collaboration and invite
Requirements
a diversity of perspectives, drawing on a variety of talents to create a wealth of possibilities.We prize innovation and seek intelligent solutions using leading-edge technology.Here at Cytel we want our employees to succeed and we enable this success through consistent training, development and support. To be successful in this position you will have: Bachelorâs degree in one of the following fields Statistics, Computer Science, Mathematics, etc.At least 8 years of SAS programming working with clinical trial data in the Pharmaceutical & Biotech industry with a bachelorâs degree or equivalent. At least 6 years of related experience with a masterâs degree or above.Study lead experience, preferably juggling multiple projects simultaneously preferred.Strong SAS data manipulation, analysis and reporting skills.Solid experience implementing the latest CDISC SDTM / ADaM standards.Strong QC / validation skills.Good ad-hoc reporting skills. Proficiency in Efficacy analysis.Familiarity with drug development life cycle and experience with the manipulation, analysis and reporting of clinical trialsâ data.Submissions experience utilizing define.xml and other submission documents.Experience supporting immunology, respiratory or oncology studies would be a plus.Excellent analytical & troubleshooting skills.Ability to provide quality output and deliverables, in adherence with challenging timelines.Ability to work effectively and successfully in a globally dispersed team environment with cross-cultural partners.How you will contribute:Performing data manipulation, analysis and reporting of clinical trial data, both safety and efficacy (ISS/ISE), utilizing SAS programmingGenerating and validating SDTM and ADaM datasets/analysis files, and tables, listings, and figures (TLFs)Production and QC / validation programmingGenerating complex ad-hoc reports utilizing raw dataApplying strong understanding/experience of Efficacy analysisCreating and reviewing submission documents and eCRTsCommunicating with and/or responding to internal cross-functional teams and client for project specifications, status, issues or inquiriesPerforming lead duties when called uponServing as team player, with a willingness to go the extra distance to get results, meet deadlines, etc.Being adaptable and flexible when priorities changeFull timePosting Date: 2026-08-05
Apply for this position
This job is hosted externally. Click below to view the full posting and apply.
Prepare application
- Draft this with your agent
- Open in Claude
- Open in ChatGPT
Good distractions
Talks and stories from around this role â technically off-topic, practically not.
Moments
Explore playlistsVideos
See allRelated articles
See all
Data Analyst Salary in the UK
The Most Popular IT Jobs on the Market
The 12 Best Jobs for Software Engineers
Top 6 Hackathons for Developers in 2023